Novartis unit Sandoz agrees to pay $195 million to resolve antitrust charges

Canada

FILE PHOTO: The company’s logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November 28, 2019. REUTERS/Arnd Wiegmann

WASHINGTON (Reuters) – Novartis unit Sandoz has agreed to pay $195 million to reach a deferred prosecution agreement aimed at resolving antitrust charges, the Justice Department said on Monday.

Reporting by Diane Bartz; Editing by Chris Reese

Products You May Like

Articles You May Like

Prepare to study in Canada
Study permit: Who can apply
Nurse Aides And Orderlies Can Now Immigrate To Canada Through Express Entry 
Quebec Issues 998 Canada Immigration Invitations To Candidates With Job Offers Outside Montreal
Canada To Spend $90m Improving Credential Recognition Of Immigrant Healthcare Workers
Newfoundland And Labrador Wants Its Provincial Canada Immigration Allotment Doubled
Boost PNP Slots For International Students, Conference Board Says

Leave a Reply

Your email address will not be published. Required fields are marked *